Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial.

Front Oncol · 2023 · PMC10071022 · PMID 37025596

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

did not reach statistical significanceno p-value reported

The experimental arm was associated with a favorable trend toward improved EFS versus RCT and placebo, but the difference did not reach statistical significance ( 20 ).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.